Greenwich LifeSciences (GLSI) announced an update on FLAMINGO-01 open label HLA data. Analysis of the open label data from FLAMINGO-01 has ...

Analysis of the open label data from FLAMINGO-01 has commenced and has been conducted in a manner that maintains the study blind. A preliminary review of FLAMINGO-01 HLA data in both the HLA-A*02 ...

Analysis of the open label data from FLAMINGO-01 has commenced and has been conducted in a manner that maintains the study blind ... approval by the FDA and EMA. A variety of HLA types are ...

Pfizer Inc. today announced positive results from the Phase 3 TALAPRO-2 study of TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI® (enzalutamide ...

It was a busy week for the biotech sector as the fourth-quarter earnings season kicked in. While Regeneron REGN gained following the announcement, Amgen AMGN was in the red. Meanwhile, other pipeline ...

In 152 trials (75.7%), patients were randomised to treatment or comparator, including 55 trials with some form of blinding and 97 open-label studies ... we searched for information from the European ...

The Hawaii Emergency Management Agency plans for and responds to both natural and human-caused emergencies. Because of the storm, the Emergency Operations Center was activated. It may be new to ...

On Wednesday, EMA Director Jeff Birdwell said that the outdoor warning siren system for all of Madison County is down after it failed during its monthly test. Birdwell said the failure was due to ...

The Hawaii Emergency Management Agency plans for and responds to both natural and human-caused emergencies. Because of the storm, the Emergency Operations Center was activated.

"We are pleased that EMA has confirmed that pediatric studies evaluating mesdopetam are not needed to support a market authorization application for Parkinson's disease. Since we have previously ...